Vanda Pharmaceuticals Inc. - Common Stock (VNDA)

CUSIP: 921659108

Q3 2018 13F Holders as of 30 Sep 2018

Type / Class
Equity / Common Stock
Shares outstanding
59,119,327
Total 13F shares
52,207,975
Share change
+3,185,452
Total reported value
$1,198,127,037
Put/Call ratio
33%
Price per share
$22.95
Number of holders
157
Value change
+$80,020,008
Number of buys
92
Number of sells
53

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 921659108?
CUSIP 921659108 identifies VNDA - Vanda Pharmaceuticals Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of VNDA - Vanda Pharmaceuticals Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
BlackRock Finance, Inc.
13F
Company
8.4%
4,960,924
$94,506,000 30 Jun 2018
13F
Consonance Capital Management LP
13F
Company
7.8%
4,609,043
$87,802,000 30 Jun 2018
13F
Palo Alto Investors LP
13F
Company
7%
4,155,670
$79,166,000 30 Jun 2018
13F
VANGUARD GROUP INC
13F
Company
5.7%
3,340,868
$63,645,000 30 Jun 2018
13F
Avoro Capital Advisors LLC
13F
Company
4.7%
2,800,191
$53,344,000 30 Jun 2018
13F
MACQUARIE GROUP LTD
13F
Company
4.3%
2,555,004
$48,673,000 30 Jun 2018
13F
ARMISTICE CAPITAL, LLC
13F
Company
3.8%
2,224,000
$42,367,000 30 Jun 2018
13F
STATE STREET CORP
13F
Company
3.7%
2,173,011
$41,399,000 30 Jun 2018
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
2.8%
1,681,250
$32,028,000 30 Jun 2018
13F
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
2.4%
1,400,000
$26,670,000 30 Jun 2018
13F
FMR LLC
13F
Company
2.2%
1,311,471
$24,984,000 30 Jun 2018
13F
Invesco Ltd.
13F
Company
2.1%
1,221,149
$23,263,000 30 Jun 2018
13F
MORGAN STANLEY
13F
Company
1.9%
1,149,710
$21,903,000 30 Jun 2018
13F
Cormorant Asset Management, LP
13F
Company
1.6%
957,821
$18,246,000 30 Jun 2018
13F
FIRST MANHATTAN CO. LLC.
13F
Company
1.6%
956,866
$18,228,000 30 Jun 2018
13F
PRUDENTIAL FINANCIAL INC
13F
Company
1.4%
830,239
$15,816,000 30 Jun 2018
13F
TEACHERS ADVISORS, LLC
13F
Company
1.2%
720,101
$13,718,000 30 Jun 2018
13F
TIAA CREF INVESTMENT MANAGEMENT LLC
13F
Company
1.2%
685,336
$13,056,000 30 Jun 2018
13F
NORTHERN TRUST CORP
13F
Company
1.1%
676,300
$12,884,000 30 Jun 2018
13F
Stonepine Capital Management, LLC
13F
Company
1%
600,000
$11,430,000 30 Jun 2018
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.96%
564,920
$10,761,000 30 Jun 2018
13F
ROTHSCHILD & CO ASSET MANAGEMENT US INC.
13F
Company
0.76%
450,021
$8,573,000 30 Jun 2018
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.66%
391,939
$7,467,000 30 Jun 2018
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
0.66%
390,402
$7,437,000 30 Jun 2018
13F
TWO SIGMA INVESTMENTS, LP
13F
Company
0.6%
354,751
$6,758,000 30 Jun 2018
13F
D. E. Shaw & Co., Inc.
13F
Company
0.58%
340,896
$6,494,000 30 Jun 2018
13F
PANAGORA ASSET MANAGEMENT INC
13F
Company
0.55%
326,138
$6,213,000 30 Jun 2018
13F
JPMORGAN CHASE & CO
13F
Company
0.53%
310,770
$5,920,000 30 Jun 2018
13F
BAKER BROS. ADVISORS LP
13F
Company
0.52%
310,354
$5,912,000 30 Jun 2018
13F
Man Group plc
13F
Company
0.52%
304,572
$5,802,000 30 Jun 2018
13F
QS Investors, LLC
13F
Company
0.51%
302,630
$5,765,000 30 Jun 2018
13F
TWO SIGMA ADVISERS, LP
13F
Company
0.51%
300,100
$5,717,000 30 Jun 2018
13F
HAWK RIDGE CAPITAL MANAGEMENT LP
13F
Company
0.44%
258,877
$4,932,000 30 Jun 2018
13F
PNC FINANCIAL SERVICES GROUP, INC.
13F
Company
0.38%
223,574
$4,260,000 30 Jun 2018
13F
Bank of New York Mellon Corp
13F
Company
0.36%
214,369
$4,084,000 30 Jun 2018
13F
PICTET ASSET MANAGEMENT LTD
13F
Company
0.35%
206,700
$3,938,000 30 Jun 2018
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.35%
204,419
$3,894,000 30 Jun 2018
13F
HBK INVESTMENTS L P
13F
Company
0.32%
191,324
$3,645,000 30 Jun 2018
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.32%
189,936
$3,619,000 30 Jun 2018
13F
University Of Notre Dame du Lac
13F
Individual
0.28%
163,626
$3,117,000 30 Jun 2018
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.27%
160,753
$3,062,000 30 Jun 2018
13F
Spark Investment Management LLC
13F
Company
0.25%
147,300
$2,806,000 30 Jun 2018
13F
CADENCE CAPITAL MANAGEMENT LLC
13F
Company
0.25%
146,019
$2,782,000 30 Jun 2018
13F
BOGLE INVESTMENT MANAGEMENT L P /DE/
13F
Company
0.24%
141,882
$2,703,000 30 Jun 2018
13F
CITADEL ADVISORS LLC
13F
Company
0.24%
141,320
$2,692,000 30 Jun 2018
13F
J. Goldman & Co LP
13F
Company
0.24%
140,647
$2,679,000 30 Jun 2018
13F
Allianz Asset Management GmbH
13F
Company
0.23%
135,460
$2,581,000 30 Jun 2018
13F
DEUTSCHE BANK AG\
13F
Company
0.23%
135,063
$2,573,000 30 Jun 2018
13F
WELLS FARGO & COMPANY/MN
13F
Company
0.22%
131,265
$2,500,000 30 Jun 2018
13F
Alambic Investment Management, L.P.
13F
Company
0.21%
125,146
$2,384,000 30 Jun 2018
13F

Institutional Holders of Vanda Pharmaceuticals Inc. - Common Stock (VNDA) as of Q3 2018

As of 30 Sep 2018, Vanda Pharmaceuticals Inc. - Common Stock (VNDA) was held by 157 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 52,207,975 shares. The largest 10 holders included BlackRock Inc., Consonance Capital Management LP, Palo Alto Investors LP, Vanguard Group Inc, MACQUARIE GROUP LTD, STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, GLENMEDE TRUST CO NA, ADAGE CAPITAL PARTNERS GP, L.L.C., and FMR LLC. This page lists 157 institutional shareholders reporting positions in this security for the Q3 2018 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q3 2018 vs Q2 2018 Across Filers

Q2 2018 holders
134
Q3 2018 holders
157
Holder diff
23
Investor Q2 2018 Shares Q3 2018 Shares Share Diff Share Chg % Q2 2018 Value $ Q3 2018 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.